Literature DB >> 6095609

Dosimetric precision requirements in radiation therapy.

A Brahme.   

Abstract

Based on simple radiobiologic models the effect of the true distribution of absorbed dose in therapy beams on the response of uniform tumor volumes are investigated. Under assumption that the dose variation in the beam is small it is shown that the response of the tumor to radiation is determined by the mean dose to the tumor volume. Quantitative expressions are also given for the loss in tumor control probability as a function of the degree of dose variations around the mean dose level. When the dose variations are large the minimum tumor dose is best related to tumor control. It is finally shown that high tumor control rates can only be achieved with a very high accuracy in dose delivery. If the normalized dose response gradient is higher than 3, as is frequently the case, the relative standard deviation of mean dose in the target volume should be less than 3 per cent to achieve an absolute standard deviation in tumor control probability of less than 10 per cent.

Entities:  

Mesh:

Year:  1984        PMID: 6095609     DOI: 10.3109/02841868409136037

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  34 in total

Review 1.  Linear quadratic and tumour control probability modelling in external beam radiotherapy.

Authors:  S F C O'Rourke; H McAneney; T Hillen
Journal:  J Math Biol       Date:  2008-09-30       Impact factor: 2.259

2.  Evaluating target cold spots by the use of tail EUDs.

Authors:  Thomas Bortfeld; David Craft; James F Dempsey; Tarek Halabi; H Edwin Romeijn
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-25       Impact factor: 7.038

3.  Dose gradient based algorithm for beam weights selection in 3D-CRT plans.

Authors:  Marta Krystyna Giżyńska; Paweł F Kukołowicz
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-13

Review 4.  Image-guided radiotherapy: from current concept to future perspectives.

Authors:  David A Jaffray
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

5.  Dose prescription point in forward intensity-modulated radiotherapy of breast and head/neck cancers.

Authors:  Farzaneh Allaveisi; Nasrin Amini; Sohrab Sakineh Pour
Journal:  Radiol Phys Technol       Date:  2018-09-08

Review 6.  Proton therapy for tumors of the skull base.

Authors:  J E Munzenrider; N J Liebsch
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

7.  Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications.

Authors:  Leire Arbea; Luis Isaac Ramos; Rafael Martínez-Monge; Marta Moreno; Javier Aristu
Journal:  Radiat Oncol       Date:  2010-02-26       Impact factor: 3.481

Review 8.  A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer.

Authors:  Patricia Diez; Ivan S Vogelius; Søren M Bentzen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-10-31       Impact factor: 7.038

9.  Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.

Authors:  Catharine H Clark; Edwin G A Aird; Steve Bolton; Elizabeth A Miles; Andrew Nisbet; Julia A D Snaith; Russell A S Thomas; Karen Venables; David I Thwaites
Journal:  Br J Radiol       Date:  2015-09-02       Impact factor: 3.039

10.  Remarks on reporting and recording consistent with the ICRU reference dose.

Authors:  Klaus Bratengeier; Markus Oechsner; Mark Gainey; Michael Flentje
Journal:  Radiat Oncol       Date:  2009-10-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.